Detalhe da pesquisa
1.
Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques.
Cell
; 183(1): 185-196.e14, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007262
2.
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.
Immunity
; 50(1): 241-252.e6, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552025
3.
Long-acting capsid inhibitor protects macaques from repeat SHIV challenges.
Nature
; 601(7894): 612-616, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875675
4.
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.
Immunity
; 46(6): 1073-1088.e6, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28636956
5.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
; 584(7821): 443-449, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668443
6.
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Nature
; 586(7830): 583-588, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731257
7.
High Frequency of Prior SARS-CoV-2 Infection by Sensitive Nucleocapsid Assays.
J Infect Dis
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566610
8.
HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys.
PLoS Pathog
; 18(4): e1010467, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452496
9.
Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.
Nature
; 564(7734): E8, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30397346
10.
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.
Nature
; 563(7731): 360-364, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30283138
11.
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
J Virol
; 95(11)2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33727331
12.
Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques.
J Virol
; 95(8)2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33472939
13.
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys.
Nature
; 540(7632): 284-287, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27841870
14.
Vaccine protection against Zika virus from Brazil.
Nature
; 536(7617): 474-8, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27355570
15.
Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Nature
; 590(7844): E25, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469218
16.
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
JAMA
; 325(15): 1535-1544, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704352
17.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Lancet
; 392(10143): 232-243, 2018 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047376
18.
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
J Virol
; 92(13)2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29643249
19.
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.
Nature
; 503(7475): 224-8, 2013 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24172905
20.
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.
J Virol
; 89(5): 2507-19, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540368